Jade Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JBIO and other ETFs, options, and stocks.About JBIO
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.
CEOTom Frohlich
CEOTom Frohlich
Employees30
Employees30
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2018
Founded2018
Employees30
Employees30
JBIO Key Statistics
Market cap777.47M
Market cap777.47M
Price-Earnings ratio-1.48
Price-Earnings ratio-1.48
Dividend yield—
Dividend yield—
Average volume555.04K
Average volume555.04K
High today$17.10
High today$17.10
Low today$16.59
Low today$16.59
Open price$16.59
Open price$16.59
Volume36.13K
Volume36.13K
52 Week high$100.10
52 Week high$100.10
52 Week low$6.57
52 Week low$6.57
Stock Snapshot
As of today, Jade Biosciences(JBIO) shares are valued at $16.90. The company's market cap stands at 777.47M, with a P/E ratio of -1.48.
As of 2025-12-23, Jade Biosciences(JBIO) stock has fluctuated between $16.59 and $17.10. The current price stands at $16.90, placing the stock +1.9% above today's low and -1.2% off the high.
Jade Biosciences(JBIO) shares are trading with a volume of 36.13K, against a daily average of 555.04K.
During the past year, Jade Biosciences(JBIO) stock moved between $6.57 at its lowest and $100.10 at its peak.
During the past year, Jade Biosciences(JBIO) stock moved between $6.57 at its lowest and $100.10 at its peak.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own JBIO. This list is generated using Robinhood data, and it’s not a recommendation.